Bogdán Sándor, Németh Zsolt, Huszár Tamás, Ujpál Márta, Barabás József, Szabó György
Semmelweis Egyetem, Fogorvostudományi Kar Arc-, Allcsont-, Szájsebészeti és Fogászati Klinika Budapest Mária u. 52. 1085.
Orv Hetil. 2009 Feb 15;150(7):305-11. doi: 10.1556/OH.2009.28553.
Whereas autologous bone replacement was earlier applied in maxillofacial surgery virtually only for the restoration of mandibular defects and for the osteoplasty of patients with cleft alveolar process, the free transplantation of autologous bone (spongiosa or cortical bone or both) is nowadays primarily used for implantation purposes. Autologous bone is still the gold standard for bone replacement. This is the case even though a wide selection of bone substitutes is currently available, with which new bone equivalent to autologous bone can be produced in certain cases. Autologous bone is often obtained from intraoral sources, but if a larger quantity of spongiosa is required, these sites (the chin, the retromolar area of the mandible, the muscular process, etc.) are not suitable. Of the extraoral donor sites, the most frequently used site is the iliac crest, but the proximal epiphysis of the tibia is also appropriate for this purpose since we have recently performed bone transplantations on appreciable numbers of patients, we decided to compare the morbidity data relating to the two donor sites. In the 9 months between March and November 2007, sinus elevations were carried out on 14 patients with bone taken from the tibia, while in 38 patients bone was taken from the iliac crest for osteoplasty on clefted alveolar process. The comparison was based on postoperative clinical examinations, the complaints of the patients and objective study of the morbidity relating to the two donor sites. Clinically the patients tolerated both interventions well. Mobilization took place on the day of intervention. There were no major complications; one minor haematoma was observed after each type of surgery. The postoperative complaints of the patients did not reveal any essential difference. Following bone harvesting from the iliac crest, the gait of the patients slightly hampered for up to 10 to 14 days. In the tibia cases, the patients experienced no pain on walking by the second day. As regards donor site morbidity, protracted (1-2 weeks) oedema was observed after hip surgery, with paraesthesia of the area of innervation of the n. cutaneous femoris lateralis in 1 case, while there was a minor seroma following tibia surgery in 1 case. Our clinical experience suggests that, if 10-15 cm(3) spongiosa is required for augmentation purposes and there is no need for cortical bone, the patient is exposed to less stress when bone is taken from the proximal epiphysis of the tibia.
尽管自体骨移植早期在颌面外科几乎仅用于修复下颌骨缺损以及牙槽突裂患者的骨成形术,但如今自体骨(松质骨或皮质骨或两者)的游离移植主要用于植入目的。自体骨仍然是骨替代的金标准。即便目前有多种骨替代物可供选择,在某些情况下使用它们能够生成与自体骨相当的新骨,情况依然如此。自体骨通常取自口腔内,但如果需要大量松质骨,这些部位(下巴、下颌磨牙后区、肌突等)并不合适。在口腔外供体部位中,最常使用的部位是髂嵴,但胫骨近端骨骺也适用于此目的。由于我们最近对相当数量的患者进行了骨移植,我们决定比较这两个供体部位的发病数据。在2007年3月至11月的9个月期间,对14例患者取自胫骨的骨进行了上颌窦提升术,而对38例患者取自髂嵴的骨进行了牙槽突裂骨成形术。比较基于术后临床检查、患者的主诉以及对两个供体部位发病情况的客观研究。临床上患者对这两种手术耐受良好。干预当天即可活动。未出现重大并发症;每种手术各观察到1例轻微血肿。患者的术后主诉未显示出任何本质差异。取自髂嵴的骨后,患者的步态在长达10至14天内略有受限。在胫骨手术病例中,患者在第二天行走时就没有疼痛了。关于供体部位发病情况,髋部手术后观察到持续(1至2周)水肿,1例出现股外侧皮神经支配区域感觉异常,而胫骨手术后1例出现轻微血清肿。我们的临床经验表明,如果为增加骨量需要10 - 15立方厘米的松质骨且不需要皮质骨,从胫骨近端骨骺取骨时患者承受的压力较小。